AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (7 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access | Online First

Landscape of liver organoids, liver cancer organoids, and other liver disease organoids

Yuting Fang1, Xin Zhang2,3, Ji Wang1( ), Xinxin Han4,5,6( )
School of Public Health, Capital Medical University, Beijing 100069, China
Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai 200032, China
Research Unit of Liver Cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences, Beijing 100010, China
Shanghai Lisheng Biotech, Shanghai 200092, China
Organ Regeneration X Lab, LiSheng East China Institute of Biotechnology, Peking University, Nantong 226299, China
AGRI-animal organoid institute, South China Agricultural University, Guangzhou 510642, China
Show Author Information

Abstract

The liver is the body’s central metabolic organ. Liver organoids have emerged as powerful tools to model it. Three-dimensional organoid systems are expected to reproduce many key liver functions. These functions include detoxification, protein synthesis, and bile production. Liver organoids allow researchers to study liver biology, disease mechanisms, and drug responses in vitro. This review systematically examines liver organoid development. We cover classification, cellular origins, cellular complexity, microenvironment composition, maturation state, translational status, culture methods, and applications. We detail several organoid types. Some derive from embryonic stem cells, induced pluripotent stem cells, or adult stem cells. Others are derived from patients’ tumor tissues and tumor-related samples for liver cancer organoid generation. These include hepatocellular carcinoma organoids, intrahepatic cholangiocarcinoma organoids, and metastatic lesion organoids. We also discuss other disease-specific organoids. These model metabolic dysfunction-associated steatotic liver disease (MASLD), cirrhosis, viral hepatitis, and autoimmune disorders. The review explores key applications. These include basic research, drug discovery, toxicology testing, and regenerative medicine. We also consider future directions, such as bioartificial liver systems. By synthesizing recent advances, this work provides a comprehensive reference. It shows how liver organoids are advancing liver disease research and translational applications.

Graphical Abstract

This review compares normal, cancer, and other liver disease organoids by cell source, cellular complexity, microenvironment, maturation, and intended use. It evaluates adult hepatocyte, multicellular, vascularized, and zonated systems for disease modeling and drug testing, while distinguishing established research applications from investigational precision oncology, transplantation, and bioartificial liver support.

References

【1】
【1】
 
 
Cell Organoid

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Fang Y, Zhang X, Wang J, et al. Landscape of liver organoids, liver cancer organoids, and other liver disease organoids. Cell Organoid, 2026, https://doi.org/10.26599/CO.2026.9410026

9

Views

0

Downloads

0

Crossref

Received: 13 February 2026
Revised: 31 August 2026
Accepted: 22 September 2026
Published: 19 November 2026
© The Author(s) 2026. Published by Tsinghua University Press

The articles published in this open access journal are distributed under the termsof the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution andreproduction in any medium, provided the original work is properly cited.